Procirca, Inc.

Pittsburgh, PA Doing business as Upmc Procirca Part of Upmc

UEI
KF9MNLQLWH94
CAGE
1HDP1
Primary NAICS
621399 Offices of All Other Miscellaneous Health Practitioners
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Upmc, ranks:

Its parent company, University of Pittsburgh Medical Center, ranks #87 in PSC Q5

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
200 Lothrop St, Pittsburgh, PA 15213, USA
Website
procirca.com
Founded
1981
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $360,905
FY2025 $417,058
FY2024 $195,781
FY2023 $246,612

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $360,905

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Procirca, Inc., doing business as UPMC Procirca, is a for-profit subsidiary of the University of Pittsburgh Medical Center (UPMC) specializing in advanced perfusion technologies and equipment maintenance services critical to organ transplantation and cardiac care. The company is registered in SAM.gov and holds an active federal contracting capability, with its principal place of business located in Pittsburgh, Pennsylvania. As a specialized medical services provider, Procirca has established itself as a strategic partner to the U.S. Department of Veterans Affairs, delivering essential cardiac and liver perfusion services that support veteran healthcare initiatives across multiple regions.

Procirca has demonstrated a consistent track record of federal contract awards exclusively from the Department of Veterans Affairs, Veterans Integrated Service Network 4, with contract values ranging from $7,012 to $451,731.48. The company's service portfolio encompasses cardiac and liver perfusion services, perfusion equipment procurement, and associated equipment maintenance support, all delivered on a firm fixed-price basis without set-aside designations, indicating competitive procurement processes. Past delivery order contracts awarded to Procirca span from January 2022 through December 2025, with performance locations in Pittsburgh and Aspinwall, Pennsylvania. Notable recent awards include a $451,731.48 delivery order issued on December 30, 2025, for cardiac and liver perfusion services with completion scheduled for December 29, 2026, and a $229,802.94 delivery order awarded on July 1, 2025. Historical awards also reflect periods where the company operated under the legal name Biotronics, Inc., demonstrating continuity of service provision despite corporate naming conventions. The cumulative value of identified delivery orders extends beyond $1.8 million since 2022, underscoring the VA's reliance on Procirca's specialized capabilities.

Procirca currently holds a single-award indefinite delivery contract issued by the Department of Veterans Affairs, Veterans Integrated Service Network 4, with a ceiling value of $229,802.94 and an ultimate completion date of December 31, 2025. This indefinite delivery contract authorizes the VA to procure cardiac and liver perfusion services and equipment maintenance on an as-needed basis throughout the VISN 4 region and adjacent areas, enabling flexible access to specialized medical expertise without requiring separate competitive procurements for individual service requirements. The contract structure supports the continuity of critical clinical services essential to organ transplantation programs and advanced cardiac care protocols for the veteran population, and multiple delivery orders have been issued against this vehicle to address specific service requirements. The indefinite delivery contract mechanism positions Procirca as an established, competitively vetted provider for the VA's ongoing perfusion service needs, demonstrating the agency's confidence in the contractor's technical expertise and operational capabilities.

Quick answers

Is Procirca, Inc. registered in SAM.gov?

Yes. Procirca, Inc.'s SAM.gov registration is active through June 4, 2027.

How much has Procirca, Inc. received in federal contracts?

Federal contracts obligated $417,058 to Procirca, Inc. in fiscal year 2025 and $1,220,356 in fiscal years 2023 through 2027.

How does Procirca, Inc. rank among federal contractors?

Procirca, Inc.'s parent company, Upmc, ranked #46 in PSC Q523, #64 in NAICS 62139 and #88 in NAICS 6213 in FY2025.

What is Procirca, Inc.'s most recent federal award?

Procirca, Inc.'s most recent federal contract award is Cardiac/liver perfusion (36C24426N0275), from Veterans Integrated Service Network 4 (VHA), on December 30, 2025.

On GovTribe

See Procirca, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors